Richard A. Elion, MD

Trio Health

Disclosure(s): Gilead Sciences: Advisor/Consultant, Grant/Research Support; Trio Health: Employee; ViiV Healthcare: Advisor/Consultant, Grant/Research Support

Poster(s):

• (P-328) PrEP Utilization Patterns and Indications in a Cohort of HIV-Negative Individuals
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-382) Characteristics and Outcomes of People with HIV (PWH) with Suboptimal Adherence on B/F/TAF or Dolutegravir Single-Tablet Regimens (STRs)
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET